Shanmuga Hospital Ltd vs Syngene International Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Shanmuga Hospital Ltd is ₹ 42 as of 29 Oct 15:30 . The P/E Ratio of Shanmuga Hospital Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Syngene International Ltd changed from 53.7 on March 2021 to 49.7 on March 2026 . This represents a CAGR of -1.28% over 6 years The Market Cap of Shanmuga Hospital Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Syngene International Ltd changed from ₹ 21734 crore on March 2021 to ₹ 15724 crore on March 2026 . This represents a CAGR of -5.25% over 6 years The revenue of Shanmuga Hospital Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Syngene International Ltd for the Sep '26 is ₹ 860.7 crore as compare to the Jun '26 revenue of ₹ 761.3 crore. This represent the growth of 13.06% The ebitda of Shanmuga Hospital Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Syngene International Ltd for the Sep '26 is ₹ 168.7 crore as compare to the Jun '26 ebitda of ₹ 102.6 crore. This represent the growth of 64.42% The net profit of Shanmuga Hospital Ltd changed from ₹ 0 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of 0.0% The net profit of Syngene International Ltd changed from ₹ 75.7 crore to ₹ 32.2 crore over 10 quarters. This represents a CAGR of -28.96% The Dividend Payout of Shanmuga Hospital Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Syngene International Ltd changed from 10.18 % on March 2022 to 16.52 % on March 2026 . This represents a CAGR of 10.17% over 5 years .

About Shanmuga Hospital Ltd

Shanmuga Hospital Limited was originally incorporated as a Private Limited Company under the name 'Shanmuga Hospital Private Limited' on June 26, 2020.
It received a fresh Certificate of Incorporation, from the Registrar of Companies, Central Registration Centre.
Subsequently, the status converted into a Public Company, resulting in a name change to 'Shanmuga Hospital Limited.' This alteration was formally recorded in a new Certificate of Incorporation dated June 06, 2024, issued by the Registrar of Companies, Central Processing Centre. In 1981, Dr. Panneerselvam P. Shanmugam, started a hospital with the name of Shanmuga Hospital' as a sole proprietorship in Salem town of Tamil Nadu State.
Recognizing the demand for increased bed capacity and lack of space, the hospital was relocated in 1992 and formed a Partnership Firm in the name of 'Shanmuga Hospital' to run the said Hospital.

About Syngene International Ltd

Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
Headquartered in India, the operations are driven by its highly qualified teams comprising 5641 scientists and its state-of-the-art facilities, spread over 2.5 million sq. ft., across 3 locations in India: Bangalore, Hyderabad and Mangalore.
The Company operate into 4 business divisions comprising of Discovery Services, Development Services, Manufacturing Services and the Dedicated Centers. Syngene International Limited was incorporated at Bangalore in 1993.
The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
The Company's health-related services extend across all major therapeutic areas and modalities.

FAQs for the comparison of Shanmuga Hospital Ltd and Syngene International Ltd

Which company has a larger market capitalization, Shanmuga Hospital Ltd or Syngene International Ltd?

Market cap of Shanmuga Hospital Ltd is 57 Cr while Market cap of Syngene International Ltd is 16,251 Cr

What are the key factors driving the stock performance of Shanmuga Hospital Ltd and Syngene International Ltd?

The stock performance of Shanmuga Hospital Ltd and Syngene International Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Shanmuga Hospital Ltd and Syngene International Ltd?

As of October 31, 2026, the Shanmuga Hospital Ltd stock price is INR ₹42.0. On the other hand, Syngene International Ltd stock price is INR ₹402.6.

How do dividend payouts of Shanmuga Hospital Ltd and Syngene International Ltd compare?

To compare the dividend payouts of Shanmuga Hospital Ltd and Syngene International Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.